---
figid: PMC6457262__nihms-992938-f0001
figlink: /pmc/articles/PMC6457262/figure/F1/
number: F1
caption: In the kynurenine pathway, tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase
  convert tryptophan into N-formyl-L-kynurenine, which is further metabolized to L-kynurenine
  by formamidase. L-kynurenine is metabolized into kynurenic acid (KYNA) and quinolinic
  acid along distinct pathways within the brain due to their reliance on the respective
  kynurenine aminotransferase and kynurenine 3-hydroxylase enzymes. KYNA has inhibitory
  action on α7 nicotinic and NMDA receptors. Galantamine and memantine cross the blood-brain
  barrier and would target α7 nicotinic and NMDA receptors, thereby counteracting
  tire effects of KYNA.
pmcid: PMC6457262
papertitle: 'Galantamine-memantine combination superior to donepezil-memantine combination
  in Alzheimer’s disease: critical dissection with an emphasis on kynurenic acid and
  mismatch negativity.'
reftext: Maju Mathew Koola, et al. J Geriatr Care Res. 2018;5(2):57-67.
pmc_ranked_result_index: '88598'
pathway_score: 0.8113587
filename: nihms-992938-f0001.jpg
figtitle: 'Galantamine-memantine combination superior to donepezil-memantine combination
  in Alzheimer’s disease: critical dissection with an emphasis on kynurenic acid and
  mismatch negativity'
year: '2018'
organisms:
- Homo sapiens
ndex: c9ebc8a8-df28-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6457262__nihms-992938-f0001.html
  '@type': Dataset
  description: In the kynurenine pathway, tryptophan 2,3-dioxygenase and indoleamine
    2,3-dioxygenase convert tryptophan into N-formyl-L-kynurenine, which is further
    metabolized to L-kynurenine by formamidase. L-kynurenine is metabolized into kynurenic
    acid (KYNA) and quinolinic acid along distinct pathways within the brain due to
    their reliance on the respective kynurenine aminotransferase and kynurenine 3-hydroxylase
    enzymes. KYNA has inhibitory action on α7 nicotinic and NMDA receptors. Galantamine
    and memantine cross the blood-brain barrier and would target α7 nicotinic and
    NMDA receptors, thereby counteracting tire effects of KYNA.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IDO1
  - ACMSD
  - GRIN3A
  - GRIN2A
  - GRIN2D
  - TSTD1
  - KMO
  - QPRT
  - GRIN2B
  - GRIN3B
  - GRIN1
  - GRIN2C
  - Tryptophan
  - Indoleamine
  - Kynurenine
  - Kupigenine
  - 3-hydroxykynurenine
  - Anthranilic acid
  - Kynurenic acid
  - NMDA
  - 5-hydroxy-anthranilic acid
  - 3-hydroxyanthranilic acid
  - 3-liydroxylanthraniate 3,4
  - 2-amini-3-carboxymuconate
  - 2-amino-3-carboxymuconate
  - semialdehyde
  - Picolinic acid
  - Quinolinic acid
  - Quinolinate phosphoribosyl
  - Nicotinamide
  - KAT
  - semialdehyde
genes:
- word: (IDO)
  symbol: IDO
  source: hgnc_prev_symbol
  hgnc_symbol: IDO1
  entrez: '3620'
- word: (ACMSD)
  symbol: ACMSD
  source: hgnc_symbol
  hgnc_symbol: ACMSD
  entrez: '130013'
- word: NMDA-R
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN3A
  entrez: '116443'
- word: NMDA-R
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2A
  entrez: '2903'
- word: NMDA-R
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2D
  entrez: '2906'
- word: (KAT)
  symbol: KAT
  source: hgnc_alias_symbol
  hgnc_symbol: TSTD1
  entrez: '100131187'
- word: (KMO)
  symbol: KMO
  source: hgnc_symbol
  hgnc_symbol: KMO
  entrez: '8564'
- word: (QPRT)
  symbol: QPRT
  source: hgnc_symbol
  hgnc_symbol: QPRT
  entrez: '23475'
- word: NMDA-R
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2B
  entrez: '2904'
- word: NMDA-R
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN3B
  entrez: '116444'
- word: NMDA-R
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN1
  entrez: '2902'
- word: NMDA-R
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2C
  entrez: '2905'
chemicals:
- word: Tryptophan
  source: ''
  identifier: ''
- word: Indoleamine
  source: ''
  identifier: ''
- word: Kynurenine
  source: MESH
  identifier: C029366
- word: Kupigenine
  source: ''
  identifier: ''
- word: 3-hydroxykynurenine
  source: MESH
  identifier: C402223
- word: Anthranilic acid
  source: MESH
  identifier: C031385
- word: Kynurenic acid
  source: MESH
  identifier: D007736
- word: NMDA
  source: ''
  identifier: ''
- word: 5-hydroxy-anthranilic acid
  source: MESH
  identifier: C031385
- word: 3-hydroxyanthranilic acid
  source: MESH
  identifier: D015095
- word: 3-liydroxylanthraniate 3,4
  source: MESH
  identifier: C052614
- word: 2-amini-3-carboxymuconate
  source: MESH
  identifier: C558759
- word: 2-amino-3-carboxymuconate
  source: MESH
  identifier: C558759
- word: semialdehyde
  source: MESH
  identifier: C009338
- word: Picolinic acid
  source: MESH
  identifier: C030614
- word: Quinolinic acid
  source: MESH
  identifier: D017378
- word: Quinolinate phosphoribosyl
  source: MESH
  identifier: D017378
- word: Nicotinamide
  source: MESH
  identifier: D009536
diseases:
- word: KAT
  source: ''
  identifier: ''
- word: semialdehyde
  source: MESH
  identifier: C566402
figid_alias: PMC6457262__F1
redirect_from: /figures/PMC6457262__F1
figtype: Figure
---
